Validation of a microRNA-based Fecal (miRFec) Test for Colorectal Cancer Screening, Surveillance and Diagnosis
Condition(s) studied
Investigational drug(s) / intervention(s)
miRFec test: The miRFec test actually corresponds to the combination of fecal hemoglobin concentration (ie. FIT) and fecal miRNA expression
Study summary
The present study aims to compare effectiveness and cost-effectiveness of the miRFec test with respect to fecal immunochemical test (FIT) for the detection of advanced colorectal neoplasm among individuals participating in colorectal cancer (CRC) screening, surveillance and diagnosis.
Eligibility
Primary outcome measure(s)
- Sensitivity for advanced colorectal neoplasm — Through study completion, an average of 3 years
To compare the sensitivity of the miRFec test with respect to FIT for the detection of advanced colorectal neoplasm
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hospital Clinic of Barcelona | Barcelona | Spain | Recruiting |
More Fundacion Clinic per a la Recerca Biomédica trials in Spain
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05346757 on ClinicalTrials.gov ↗ ← All trials in Spain